|
|
Article: Oneida's blood tests assess liver disease in hep C patients.(Oneida TheraDiagnostics )(Brief Article)
- Article from:
- Pharma Marketletter
- Article date:
- November 29, 2004
CopyrightCOPYRIGHT 2004 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
UK firm Oneida TheraDiagnostics says it has launched a testing service using two new blood tests - FibroTest and ActiTest - that enables doctors to assess the extent of liver disease in hepatitis C virus infected patients without the need for a liver biopsy.
Around 200,000 people in the UK are thought to be chronically infected with the virus and, if left untreated, around one in five will develop cirrhosis of the liver; HCV is now the leading reason for liver transplantation in the UK, noted the firm.
One of the major problems with chronic HCV infection is that it can be difficult to assess the severity of the condition and liver biopsy has long been ...